On June 14, Alligator Bioscience AB (publ) announced the appointment of Johan Giléus as the company's new Chief Financial Officer as of August 12, 2024, to oversee financial strategy and operations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 SEK | 0.00% |
|
+10.72% | +82.87% |
07-11 | Transcript : Alligator Bioscience AB, Q2 2024 Earnings Call, Jul 11, 2024 | |
07-11 | Alligator Bioscience AB Appoints Johan Giléus as Chief Financial Officer as of August 12, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+82.87% | 90.26M | |
+22.15% | 46.56B | |
+45.94% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- ATORX Stock
- News Alligator Bioscience AB
- Alligator Bioscience AB Appoints Johan Giléus as Chief Financial Officer as of August 12, 2024